|
Title: A patient is administered aztreonam (Azactam). What is the major advantage of this monobactam over ... Post by: dudekim on Mar 6, 2019 A patient is administered aztreonam (Azactam). What is the major advantage of this monobactam over the aminoglycosides in treating P. aeruginosa?
A)It is a lower-cost medication. B)It is administered orally. C)It causes less GI distress. D)It has lower risk for hearing loss. Title: A patient is administered aztreonam (Azactam). What is the major advantage of this monobactam over ... Post by: miks on Mar 6, 2019 Content hidden
|